John Penn

John S. Penn, PhD
December 9, 2021

Vision foundation’s longtime support key to Penn’s research efforts

By Nancy Humphrey
January 23, 2020

Insights on diabetic retinopathy

A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.

By Leigh MacMillan
January 21, 2016

New targets for diabetic retinopathy

Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.

By VUMC News and Communications
February 12, 2015

VUMC’s Penn named president-elect of eye research society

John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER).

By Jessica Pasley
July 10, 2014

Meranze, Penn named to new Faculty Affairs roles

Two veteran faculty members are assuming new roles as associate deans within Vanderbilt University School of Medicine’s Office of Faculty Affairs.

By Nancy Humphrey
October 31, 2013

Penn named to vision group’s scientific advisory panel

John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, has been named to the Research to Prevent Blindness (RPB) Scientific Advisory Panel.

By Jessica Pasley
March 7, 2013

Penn seeks new look at eye disorder

John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, is seeking to change the way retinopathy of prematurity (ROP), the leading cause of childhood blindness worldwide, is treated.
By Jessica Pasley